218 related articles for article (PubMed ID: 21207078)
1. In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
Srulijes K; Mallien G; Bauer S; Dietzel E; Gröger A; Ebersbach G; Berg D; Maetzler W
J Neural Transm (Vienna); 2011 Aug; 118(8):1191-7. PubMed ID: 21207078
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
[TBL] [Abstract][Full Text] [Related]
3. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
Assogna F; Pellicano C; Cravello L; Savini C; Macchiusi L; Pierantozzi M; Stefani A; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
[TBL] [Abstract][Full Text] [Related]
5. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
[TBL] [Abstract][Full Text] [Related]
6. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
[TBL] [Abstract][Full Text] [Related]
7. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
[TBL] [Abstract][Full Text] [Related]
8. Association of PSP phenotypes with survival: A brain-bank study.
Guasp M; Molina-Porcel L; Painous C; Caballol N; Camara A; Perez-Soriano A; Sánchez-Gómez A; Garrido A; Muñoz E; Marti MJ; Valldeoriola F; Grau O; Gelpí E; Respondek G; Höglinger GH; Compta Y
Parkinsonism Relat Disord; 2021 Mar; 84():77-81. PubMed ID: 33581485
[TBL] [Abstract][Full Text] [Related]
9. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnostic value of eye movement recording in PSP-parkinsonism, Richardson's syndrome, and idiopathic Parkinson's disease.
Pinkhardt EH; Jürgens R; Becker W; Valdarno F; Ludolph AC; Kassubek J
J Neurol; 2008 Dec; 255(12):1916-25. PubMed ID: 19224319
[TBL] [Abstract][Full Text] [Related]
11. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
O'Sullivan SS; Massey LA; Williams DR; Silveira-Moriyama L; Kempster PA; Holton JL; Revesz T; Lees AJ
Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
[TBL] [Abstract][Full Text] [Related]
13. Clinical Phenotypes of Progressive Supranuclear Palsy-The Differences in Interleukin Patterns.
Madetko-Alster N; Otto-Ślusarczyk D; Wiercińska-Drapało A; Koziorowski D; Szlufik S; Samborska-Ćwik J; Struga M; Friedman A; Alster P
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894815
[TBL] [Abstract][Full Text] [Related]
14. Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.
dell'Aquila C; Zoccolella S; Cardinali V; de Mari M; Iliceto G; Tartaglione B; Lamberti P; Logroscino G
Parkinsonism Relat Disord; 2013 Nov; 19(11):980-5. PubMed ID: 23968651
[TBL] [Abstract][Full Text] [Related]
15. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
Schofield EC; Hodges JR; Macdonald V; Cordato NJ; Kril JJ; Halliday GM
Mov Disord; 2011 Feb; 26(2):256-63. PubMed ID: 21412832
[TBL] [Abstract][Full Text] [Related]
16. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
17. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
Tommasini L; Bonaccorsi J; Del Prete E; Cintoli S; Pagni C; Mazzucchi S; Palermo G; Morganti R; Frosini D; Siciliano G; Tognoni G; Ceravolo R
Clin Neuropsychol; 2023 Aug; 37(6):1207-1220. PubMed ID: 35997036
[No Abstract] [Full Text] [Related]
18. Uncovering clinical and radiological asymmetry in progressive supranuclear palsy-Richardson's syndrome.
Picillo M; Tepedino MF; Abate F; Ponticorvo S; Erro R; Cuoco S; Oksuz N; Di Salle G; Di Salle F; Esposito F; Pellecchia MT; Manara R; Barone P
Neurol Sci; 2022 Jun; 43(6):3677-3682. PubMed ID: 35106692
[TBL] [Abstract][Full Text] [Related]
19. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
[TBL] [Abstract][Full Text] [Related]
20. Differences in aphasia syndromes between progressive supranuclear palsy-Richardson's syndrome, behavioral variant frontotemporal dementia and Alzheimer's dementia.
Ransmayr L; Fuchs A; Ransmayr-Tepser S; Kommenda R; Kögl M; Schwingenschuh P; Fellner F; Guger M; Eggers C; Darkow R; Mangesius S; Ransmayr G
J Neural Transm (Vienna); 2022 Aug; 129(8):1039-1048. PubMed ID: 35821453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
